First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience
Research output: Contribution to journal › Journal article › Research › peer-review
Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.
| Original language | English |
|---|---|
| Journal | Acta Oncologica |
| Volume | 51 |
| Issue number | 1 |
| Pages (from-to) | 97-100 |
| Number of pages | 4 |
| ISSN | 0284-186X |
| DOIs | |
| Publication status | Published - 2012 |
ID: 40171608